Información del producto
JNJ-40346527 is an anti-inflammatory drug that belongs to the group of quinoline derivatives. It has been shown to have a tumor treatment effect in cancer cell lines and also inhibits the production of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). JNJ-40346527 has been shown to be effective in treating bowel disease and rheumatoid arthritis. This molecule inhibits tumor growth by stimulating the release of colony-stimulating factor, which stimulates the proliferation of blood cells. The hydroxyl group on this molecule may contribute to its activity by interacting with DNA bases.
Propiedades químicas
Consulta técnica sobre: 3D-SVB36352 JNJ-40346527
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.